| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.27 | 8e-13 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.19 | 9e-08 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.2 | 6e-05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |